Stockreport

Data on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual Meeting

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF ICE3 trial results presented by ICE3 Co-Principal Investigator Dr. Kenneth TomkovichFDA Advisory Panel voted in favor of IceCure's ProSense® cryoablation benefit-risk pr [Read more]